NewYork-Presbyterian Hospital

screenshot of EndeavorRX gameplay
Akili to study EndeavorRx as a COVID-19 brain fog treatment
By Mallory Hackett | 11:41 am | April 09, 2021
The digital therapeutic is designed to treat children ages 8 to 12 with ADHD, but the two studies announced this week will focus on an adult population.